Drug intelligence / Profile preview

8-azaxanthine

Development stage
Unknown
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01

Overview

8-Azaxanthine is a synthetic purine analog in which the carbon at position 8 of the xanthine ring is replaced by a nitrogen atom. It belongs to the triazolopyrimidine family and has notable photophysical properties such as strong fluorescence due to excited-state proton transfer (ESPT), making it useful as a molecular probe in biochemical research[5][7]. Biologically, it acts primarily as an inhibitor of urate oxidase (urate oxidase catalyzes oxidation of uric acid to allantoin) and also inhibits adenosine receptors[5]. These activities have made it valuable for studying enzyme-ligand interactions and receptor-binding mechanisms. Additionally, it demonstrates antibacterial activity against Pseudomonas aeruginosa and Trypanosoma cruzi[5]. Its main use is experimental; there are no approved medical indications or clinical trials for therapeutic use.

Other names
XanthazolAzaxanthine2,6-dioxy-8-azapurine2,6-dihydroxy-8-azapurinensc756nsc-756nsc 756
02

Targets

UOX (Urate oxidase)ADOR (Adenosine receptors)

Beyond the preview

Go deeper on 8-azaxanthine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 8-azaxanthine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call